4.3 Article

Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 29, 期 8, 页码 936-944

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/13524585231171517

关键词

Pediatric onset MS; lipidomics; relapse rate; EDSS

向作者/读者索取更多资源

This study found that altered serum lipid metabolites are associated with the risk of relapse and disability in children with multiple sclerosis (MS). Acylcarnitines and poly-unsaturated fatty acids were associated with higher relapse rates and disability, while phosphatidylethanolamines, plasmalogens, and primary bile acid metabolites were associated with lower relapse rates and lower disability. Examining lipid metabolism may provide a deeper understanding of pediatric MS.
Background: The circulating metabolome is altered in multiple sclerosis (MS), but its prognostic capabilities have not been extensively explored. Lipid metabolites might be of particular interest due to their multiple roles in the brain, as they can serve as structural components, energy sources, and bioactive molecules. Gaining a deeper understanding of the disease may be possible by examining the lipid metabolism in the periphery, which serves as the primary source of lipids for the brain. Objective: To determine if altered serum lipid metabolites are associated with the risk of relapse and disability in children with MS. Methods: We collected serum samples from 61 participants with pediatric-onset MS within 4 years of disease onset. Prospective longitudinal relapse data and cross-sectional disability measures (Expanded Disability Status Scale [EDSS]) were collected. Serum metabolomics was performed using untargeted liquid chromatography and mass spectrometry. Individual lipid metabolites were clustered into pre-defined pathways. The associations between clusters of metabolites and relapse rate and EDSS score were estimated utilizing negative binomial and linear regression models, respectively. Results: We found that serum acylcarnitines (relapse rate: normalized enrichment score [NES] = 2.1, q = 1.03E-04; EDSS: NES = 1.7, q = 0.02) and poly-unsaturated fatty acids (relapse rate: NES = 1.6, q = 0.047; EDSS: NES = 1.9, q = 0.005) were associated with higher relapse rates and EDSS, while serum phosphatidylethanolamines (relapse rate: NES = -2.3, q = 0.002; EDSS: NES = -2.1, q = 0.004), plasmalogens (relapse rate: NES = -2.5, q = 5.81E-04; EDSS: NES = -2.1, q = 0.004), and primary bile acid metabolites (relapse rate: NES = -2.0, q = 0.02; EDSS: NES = -1.9, q = 0.02) were associated with lower relapse rates and lower EDSS. Conclusion: This study supports the role of some lipid metabolites in pediatric MS relapses and disability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据